[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [PBNCategory](https://github.com/mm80843/T3.5/tree/main/docs/PBNCategory/index.md) >> Individual ID:PBN__PBNCategory_347 

# __Promote comprehensive testing and tracing, prioritize vulnerable populations, reduce diagnosis-to-surgery time, recognize stress symptoms, and improve testing accuracy.__

## Items covered in this category

* [Universal asymptomatic RT-PCR testing](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1222.md)
* [Implement regular testing, contact tracing, and isolation measures](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1461.md)
* [Widespread testing and contact tracing](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_720.md)
* [Implementation of contact tracing and testing](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_462.md)
* [Regular testing and contact tracing](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_440.md)
* [Regular testing and contact tracing programs](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2760.md)
* [Increased testing and contact tracing](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_864.md)
* [Isolate and Test with School Closure](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_425.md)
* [Reduced time from diagnosis to surgery](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_163.md)
* [Monitor reactions, provide psychosocial support and assistance, modify expectations](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2498.md)
* [Evaluate efficacy differences based on symptoms](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1187.md)
* [Address safety concerns through research, testing, and regulation](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2373.md)
* [Optimizing experimental conditions](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2990.md)
* [Voluntary testing](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_161.md)
* [Widespread testing](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_441.md)
* [Testing policy](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_772.md)
* [Increased testing in deprived areas](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_683.md)
* [Forced experimentation](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_431.md)
* [Increase testing capacity, develop rapid and accurate test kits, promote widespread testing](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2723.md)
* [Improve testing frequency and accuracy, conduct seroprevalence surveys.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2514.md)
* [Increased testing access](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1377.md)
* [Expand testing capacity, prioritize testing for high-risk individuals and settings, implement targeted testing strategies](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2032.md)
* [Promoting regular testing, contact tracing, and adherence to preventive measures](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1704.md)
* [Increase testing capacity, improved testing methods](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2129.md)
* [Improve contact tracing systems, increase testing capacity, utilize digital tools for contact tracing](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2725.md)
* [Rapid diagnostic tests](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1282.md)
* [Monitor and manage gastrointestinal symptoms, enhance diagnostic capabilities](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2215.md)
* [Robot-assisted swabbing and blood testing can speed up the process and free up staff for other tasks.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3083.md)
* [Combined use of WBE followed by clinical testing](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1206.md)
* [Recognizing stress symptoms](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_208.md)
* [Implement regular and widespread symptom monitoring and testing, both symptomatic and asymptomatic](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2039.md)
* [Staff respiratory specimens testing](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_267.md)
* [Patient respiratory and stool specimens testing](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_268.md)
* [Testing of feces or anal swab samples](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1095.md)
* [Develop and promote non-invasive testing methods, such as saliva or wastewater-based surveillance, to increase testing uptake.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3074.md)
* [Differential testing rates](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_682.md)
* [Combining multiple screening methods, widespread testing programs.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3049.md)
* [Conduct controlled experiments, consider confounding factors in analysis](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1710.md)
* [Allocate resources for testing and treatment, improve laboratory conditions.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2711.md)
* [Increase testing capacity; develop and deploy widespread testing strategies](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1890.md)
* [Increased testing in densely pop.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_684.md)
* [Improve testing methods, consider testing capacity](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2047.md)
* [Increase production and distribution of testing kits](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2284.md)
* [Implement quality control measures and validation protocols to minimize false positive results.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2561.md)
* [Increase testing frequency](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1188.md)
* [Utilize cross-population train/test-based models](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2376.md)
* [Prioritize testing and protection for vulnerable populations, such as the elderly and those with underlying health conditions.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3063.md)
* [Conduct clinical trials to determine the efficacy of drug therapies, develop new therapeutics](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1597.md)
* [Increase testing capacity and accessibility, prioritize testing for high-risk individuals and areas, utilize alternative testing methods such as wastewater-based surveillance.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3073.md)
* [Utilize AI algorithms as an initial screening tool and develop alternative diagnostic tests.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2856.md)
* [Develop rapid testing methods to reduce turnaround time](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3117.md)
* [Increase testing capacity and accessibility in deprived areas.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2540.md)
* [Increase testing capacity to include testing of mild or asymptomatic individuals to obtain a more accurate assessment of the prevalence.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2563.md)
* [Improve test sensitivity and accuracy to minimize false-negative results](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3118.md)
* [Reduce positivity rate through increased testing and strict adherence to mitigation measures](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2360.md)
* [Testing and validation of the expert systemâ€™s performance and accuracy](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3370.md)
* [Improve testing capacity and accuracy, enhance reporting systems](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2364.md)
* [Preprint servers can implement additional screening measures, and researchers should critically evaluate the quality of preprints before drawing conclusions.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3030.md)
* [Improve testing and reporting systems, increase transparency](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2850.md)
* [Evaluate the difference in efficacy between symptomatic and asymptomatic individuals.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2516.md)
* [Conducting research studies and gathering quantitative data on the outcomes and effectiveness of UBPI.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2920.md)
* [Conduct validation studies with reliable reference tests and establish validation standards](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1717.md)
* [Improve testing capacity and accuracy; increase data collection and surveillance systems](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1893.md)
* [Develop standardized and optimized testing protocols, enhance coordination and cooperation at national and international levels](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1796.md)
* [Conduct more efficacy studies in clinical settings to evaluate the impact of these measures on TB transmission](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1863.md)

